Sanofi To Establish New Vaccine Production Facility In Shenzhen

SHANGHAI - French drug maker Sanofi Aventis will build a new vaccine manufacturing facility in Shenzhen to make influenza vaccine for the Chinese market, under an agreement it signed with Chinese authorities in Beijing Nov. 26